Blood Feud: The Man Who Blew the Whistle on One of the Deadliest Drugs Ever
Series: IdeaSphere: A Platform for Today's Voices
From: Guy Rathbun
Length: 00:29:00
This story beings in the 1980's with a drug that seemd to be too good to be true. It was. Developed by a scientist working for Amgen and licensed to the pharmaceutical giant Johnson and Johnson, the blood booster was branded under three names: Procrit, Epogen and Aranesp. Like all "to good to be true" cure-alls, serious problems were discovered, but that didn't stop J&J or Amgen, nor did it alert the Federal Food and Drug Administration to investigate. So Begins the story of Blood Feud
After several years of research, journalist and author Kathleen Sharp has compiled a riveting story around three primary people, a corporate giant, and government agencies.
Also in the IdeaSphere: A Platform for Today's Voices series
Arizona vs US
(00:28:30)
From: Guy Rathbun
What are your thoughts about immigration? After listening to this interview, leave me a comment. The U.S. Supreme Court heard arguments in State of Arizona v. United States, ...
The Last Myth
(00:28:59)
From: Guy Rathbun
In the past dozen years, from Y2K to 2012, apocalyptic anticipation in America has leapt from the cultish to the mainstream. Today, nearly 60 percent of Americans believe ...
No Citizen Left Behind
(00:27:51)
From: Guy Rathbun
While teaching at an all-black middle school in Atlanta, Associate Professor of Education Meira Levinson realized that her students’ were gong to have trouble overcoming ...
Pharmageddon
(00:29:00)
From: Guy Rathbun
Pharmaceutical companies, according to Dr. David Healy, have hijacked healthcare in America, and the results are life threatening. Healy looks at the larger issues that have ...
Supreme Court Rules:
(00:28:50)
From: Guy Rathbun
From Wendell Potter’s Blog: “Since I walked away as head of communications at a top health insurance company in May of 2008, I've worked tirelessly as an outspoken critic of ...
The Hockey Stick and the Climate Wars
(00:28:59)
From: Guy Rathbun
In its 2001 report on global climate, the Intergovernmental Panel on Climate Change of the United Nations prominently featured the “Hockey Stick,” a chart showing global ...
The Global Warming Reader
(00:28:40)
From: Guy Rathbun
Into the national conversation about climate change and our planet's natural resources comes The Global Warming Reader: A Century of Writing About Climate Change, introduced ...
Women's Health
(00:28:54)
From: Guy Rathbun
Recent controversies surroundings reproductive health issues have sparked outrage among across the country. From the halls of Congress, to Richmond, Virginia where state ...
The Obama Question
(00:28:57)
From: Guy Rathbun
While attacks from the right on President Obama and his administration have been unrelenting, progressives have not shrunk from harsh words for a president whose election ...
The Self-Made Myth
(00:28:58)
From: Guy Rathbun
If one truly believes that all wealth derives from the heroic efforts of job creators and individual business leaders, it follows that government can only get in the way and ...
Related Pieces
Piece Description
This story beings in the 1980's with a drug that seemd to be too good to be true. It was. Developed by a scientist working for Amgen and licensed to the pharmaceutical giant Johnson and Johnson, the blood booster was branded under three names: Procrit, Epogen and Aranesp. Like all "to good to be true" cure-alls, serious problems were discovered, but that didn't stop J&J or Amgen, nor did it alert the Federal Food and Drug Administration to investigate. So Begins the story of Blood Feud
After several years of research, journalist and author Kathleen Sharp has compiled a riveting story around three primary people, a corporate giant, and government agencies.
Broadcast History
Broadcast on KCBX, November 23, 2011
